Congressman to drug distributors: ‘I just want you to feel shame’
(By Lev Facher for STAT) WASHINGTON — The CEO of Cardinal Health told House members he was “deeply sorry” for
Read More
Part D/Prescription Drugs
Walmart Pharmacies and Sam’s Club to limit the supply of first-time opioid prescriptions
Walmart pharmacies, as well as Sam’s Club, will soon limit the supply of first-time opioid prescriptions for acute pain to
Read MoreThe Amish pool resources for their medical care. A budget-busting gene therapy puts them in a bind
(By Eric Boodman for STAT) The meeting could determine whether the two young siblings would keep going blind. The doctor knew
Read MoreDEA shuts down Louisiana-based pharmaceutical distributor
In a rare move the Drug Enforcement Administration (DEA) has ordered a Louisiana based wholesale pharmaceutical distributor to cease sales
Read MoreReversing An Overdose Isn’t Complicated, But Getting The Antidote Can Be
(By Jake Harper for NPR) A few months ago, Kourtnaye Sturgeon helped save someone’s life. She was driving in downtown
Read MoreHow much would you pay for the miracle of gene therapy?
(By Maria Kefalas for STAT) Every day I wake up thinking about how to get gene therapy to the children
Read More‘Pharma Bro’ Shkreli Is In Prison, But Daraprim’s Price Is Still High
(By Shefali Luthra for Kaiser Health News) It was 2015 when Martin Shkreli, then CEO of Turing Pharmaceuticals and the
Read MoreFederal kickback law might be used to bring down drug prices, FDA commissioner suggests
(By Ike Swetlitz for STAT) WASHINGTON — The commissioner of the Food and Drug Administration, Scott Gottlieb, on Thursday suggested
Read MoreFentanyl and other synthetic opioids contributed to more overdose deaths in 2016 than prescription painkillers
(By Lev Facher for STAT) WASHINGTON — Synthetic opioids, particularly illicit fentanyl, contributed to more overdose deaths in the United States
Read MoreHow A Drug Company Under Pressure For High Prices Ratchets Up Political Activity
(By Jay Hancock and Elizabeth Lucas for Kaiser Health News) Business looked challenging for Novo Nordisk at the end of
Read More